The Tentamus Group, a global leader in analytical, safety, and quality assurance services, is pleased to announce the acquisition of BioMeca, a Lyon-based biotechnology company specializing in biomechanics and mechanobiology. This strategic acquisition further expands Tentamus’ expertise in the life sciences sector, particularly in the high-resolution structural and mechanical characterization of biological samples, including tissues, cells, DNA, and proteins.
BioMeca is renowned for its innovative use of Atomic Force Microscopy (AFM) and advanced imaging techniques to provide tailored solutions for health and well-being, supporting industries such as cosmetics and pharmaceuticals. By integrating BioMeca’s cutting-edge technologies and deep expertise, Tentamus will enhance its ability to deliver comprehensive, high-value services to clients worldwide, while maintaining a strong local presence in France.
